Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Aug 27, 2025 (14 months ago)

McKesson Skin Protectant (Lanolin)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

McKesson Skin Protectant, Lanolin USP, packaged in a) 5g (NDC 68599-6202-1), and b) 4oz NDC 68599-6203-4 tube, Distributed by McKesson Medical-Surgical Inc., Richmond, VA 23233.

Affected NDCs 68599-6202-01 68599-6203-04

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product codes this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Skin Protectant with Lanolin
Lanolin
NDC 68599-6202
50 g/100g Cream
Topical
McKesson Medical-Surgical Inc. OTC
Skin Protectant with Lanolin
Lanolin
NDC 68599-6203
50 g/100g Cream
Topical
McKesson OTC
Recalling firm
DermaRite Industries, LLC
NDC code
68599-6202-1
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0171-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by DermaRite Industries, LLC

All 2025 recalls
Class II · Moderate risk

UltraSure Anti-Perspirant & Deodorant

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Ongoing cGMP deviation DermaRite Industries, LLC NDC 61924-266-04 D-0177-2026
Class II · Moderate risk

San-E-Foam

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Ongoing cGMP deviation DermaRite Industries, LLC NDC 61924-107-34 D-0176-2026
Class II · Moderate risk

Renew Skin Repair Cream

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Ongoing cGMP deviation DermaRite Industries, LLC NDC 61924-405-05 D-0175-2026
Class II · Moderate risk

Renew PeriProtect

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Ongoing cGMP deviation DermaRite Industries, LLC NDC 61924-435-04 D-0174-2026

Other cgmp deviation recalls from 2025

All cgmp deviation recalls
Class II · Moderate risk

TPN bag (patient specific)

Incorrect Product Formulation: product did not contain insulin as listed in the label.

Ongoing cGMP deviation Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles D-0524-2026
Class II · Moderate risk

Toothpaste: a) COLGATE

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0287-2026
Class II · Moderate risk

Deodorant: a) Axe

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0286-2026